The Causes and Implications of Glass Delamination - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

The Causes and Implications of Glass Delamination
This article focuses on the history of glass delamination and methods that detect it, both from a compendial and a research perspective.


Pharmaceutical Technology
pp. s6-s9

References

1. FDA, "Advisory to Drug Manufacturers: Formation of Glass Lamellae in Certain Injectable Drugs" (Rockville, MD, Mar. 2011).

2. R.G. Iacocca and M.A. Allgeier, J. Mater. Sci. 42 (3), 801–811 (2007).

3. R.G. Iacocca et al., AAPS PharmSciTech 11 (3), 1340–1349 (2010).

4. R.D. Ennis et al., Pharm. Dev. Technol. 6 (3), 393–405 (2001).

5. V. Dimbleby, J. Pharm. Pharmacol. 5 969–989 (1953).

6. V. Dimbleby, Sci. Sch. Rev. 18 (1937).

7. V. Dimbleby, H.S.Y. Gill, and W.E.S. Turner, J. Soc. Glass Technol. 19, 231–243 (1935).

8. H.S. Blackmore, V. Dimbleby, and W.E.S. Turner, J. Soc. Glass Technol. 122–129 (1923).

9. A. Lavoisier, Mem. Acad. Sci. Inscr. B-Lett. Toulouse, 73–90, (1770).

10. S. Fern, D.S. McPhail, and V. Oakley, Appl. Surf. Sci. 231–232 (6), 510–514 (2004).

11. P. Rogers, D. McPhail, and J. Ryan, Glass Technol. 34 (2), 67–68 (1993).

12. C. Cailleteau et al., Nat. Mater. 7 (10), 978–983 (2008).

13. K.G. Nickel and S. Merke, Key Eng. Mater. 336–338 (4), 1823–1826 (2007).

14. C.M. Jantzen, "Thermodynamic Approach to Glass Corrosion," in Corrosion of Glass, Ceramics, and Ceramic Superconductors: Principles, Testing, Chracterization and Applications, D.E. Clark and B.K. Zoitis, Eds. (Noyes Publications, Park Ridge, NJ, 1992), pp. 153–217.

15. W.B. White, "Theory of Corrosion of Glass and Ceramics," in Corrosion of Glass, Ceramics, and Ceramic Superconductors: Principles, Testing, Chracterization and Applications, D.E. Clark and B.K. Zoitis, Eds. (Noyes Publications, Park Ridge, NJ, 1992), pp. 2–28.

16. L. Liu et al., Invest. Ophthalmol. Vis. Sci. 52 (2), 1023–1034 (2011).

17. J.S. Bee et al., Biotechnol. Bioeng. 105 (1), 121–129 (2010).

18. J.S. Bee et al., J. Pharm. Sci. 98 (9), 3218–3238 (2009).

19. M. Hoehne et al., J. Pharm. Sci. 100 (1), 123–132 (2011).

20. A. Rosenberg, AAPS J. 8 (3), E501–E507 (2006).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology,
Click here